Local Control for Intermediate-Risk Rhabdomyosarcoma: Results From D9803 According to Histology, Group, Site, and Size: A Report From the Children's Oncology Group

This publication has 13 references indexed in Scilit:

• Delayed primary excision with subsequent modification of radiotherapy dose for intermediate‐risk rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee
  International Journal of Cancer, 2014
• A dosimetric comparison of proton and intensity modulated radiation therapy in pediatric rhabdomyosarcoma patients enrolled on a prospective phase II proton study
  Radiotherapy and Oncology, 2014
• Dense Pattern of Embryonal Rhabdomyosarcoma, a Lesion Easily Confused With Alveolar Rhabdomyosarcoma
  American Journal of Clinical Pathology, 2013
• Parameningeal Rhabdomyosarcoma: Outcomes and Opportunities
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
• Children's Oncology Group's 2013 blueprint for research: Soft tissue sarcomas
  Pediatric Blood & Cancer, 2012
• Vincristine, Actinomycin, and Cyclophosphamide Compared With Vincristine, Actinomycin, and Cyclophosphamide Alternating With Vincristine, Topotecan, and Cyclophosphamide for Intermediate-Risk Rhabdomyosarcoma: Children's Oncology Group Study D9803
  Journal of Clinical Oncology, 2009
• Failure Pattern and Factors Predictive of Local Failure in Rhabdomyosarcoma: A Report of Group III Patients on the Third Intergroup Rhabdomyosarcoma Study
  Journal of Clinical Oncology, 2004
• Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma—a report from the IRSG 1 1For a complete list of the members of the Children’s Oncology Group Soft Tissue Sarcoma Committee (formerly Intergroup Rhabdomyosarcoma Group) representing the Children’s Oncology Group and the Quality Assurance Review Center, see the Appendix.
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2001
• Intergroup Rhabdomyosarcoma Study-IV: Results for Patients With Nonmetastatic Disease
  Journal of Clinical Oncology, 2001
• The Third Intergroup Rhabdomyosarcoma Study.
  Journal of Clinical Oncology, 1995